Status:
NOT_YET_RECRUITING
CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI
Lead Sponsor:
University of Gaziantep
Conditions:
Metabolic Syndrome
Cardiovascular Diseases
Eligibility:
All Genders
30-79 years
Brief Summary
This cross-sectional study aims to determine the prevalence of Cardiovascular-Kidney-Metabolic (CKM) syndrome in a community-based adult population in Gaziantep, Türkiye. In addition to estimating the...
Detailed Description
Cardiovascular diseases, diabetes, and chronic kidney diseases are among the leading causes of morbidity and mortality both globally and in Türkiye \[1\]. The Cardiovascular-Kidney-Metabolic (CKM) Syn...
Eligibility Criteria
Inclusion
- Inclusion Criteria Age between 30 and 79 years Residence in Gaziantep, Türkiye
- Availability of the following laboratory tests performed within the past 1 month:
- Fasting glucose HbA1c Lipid profile (total cholesterol, LDL, HDL, triglycerides) Creatinine Estimated glomerular filtration rate (eGFR) Ability to provide informed consent
- Exclusion Criteria Presence of severe physical or mental disability Hospitalization due to acute illness within the past 3 months Pregnancy
Exclusion
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06944236
Start Date
June 1 2025
End Date
December 31 2025
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bağlarbaşı Family Health Center
Gaziantep, Turkey (Türkiye), 27900